--- title: "Assembly Biosciences IncQ) expected to post a loss of $1.36 a share - Earnings Preview" description: "Assembly Biosciences IncQ) is projected to report a loss of $1.36 per share and a 26.6% decline in quarterly revenue to $6.262 million for the period ending June 30, 2025. The average analyst rating r" type: "news" locale: "en" url: "https://longbridge.com/en/news/251519153.md" published_at: "2025-08-04T22:00:06.000Z" --- # Assembly Biosciences IncQ) expected to post a loss of $1.36 a share - Earnings Preview > Assembly Biosciences IncQ) is projected to report a loss of $1.36 per share and a 26.6% decline in quarterly revenue to $6.262 million for the period ending June 30, 2025. The average analyst rating remains "buy" with a median 12-month price target of $31.00, reflecting a potential upside of 40.6% from the last closing price of $18.40. Previous earnings estimates show a mix of beats and misses in recent quarters. - Assembly Biosciences Inc (ASMB.OQ) (ASMB.O) is expected to show a fall in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025 - The South San Francisco California-based company is expected to report a 26.6% decrease in revenue to $6.262 million from $8.53 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data. - ​LSEG’s mean analyst estimate for Assembly Biosciences Inc is for a loss of $1.36 per share. - The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 2 “strong buy” or “buy,” 1 “hold” and no “sell” or “strong sell.” - The mean earnings estimate of analysts was unchanged in the last three months. ​ - Wall Street’s median 12-month price target for Assembly Biosciences Inc is $31.00, about 40.6% above its last closing price of $18.40 Previous quarterly performance (using preferred earnings measure in US dollars). ​ ### QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI ### ENDING ARTESTIMAT ESTIMATE MET, SE % ### E® MISSED Mar. 31 2025 -1.60 -1.60 -1.17 Beat 26.9 Dec. 31 2025 -2.04 -1.57 Beat 23 Sep. 30 2024 -2.02 -2.02 -1.51 Beat 25.2​ Jun. 30 2024 -2.23 -2.23 -1.98 Beat 11.2 ​​Mar. -3.23 -3.23 -1.66 Beat 48.6 31 2024 Dec. 31 2023 -2.88 -2.15 Beat 25.3​ Sep. 30 2023 -2.76 -3.24 Missed -17.4 Jun. 30 2023 -3.46 -3.48 -3.84 Missed -10.3 This summary was machine generated August 4 at 22:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) ### Related Stocks - [ASMB.US - Assembly Biosciences](https://longbridge.com/en/quote/ASMB.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 21:59 ETACROBiosystems fördert Innovationen bei JPM Spotlight-Sessions von bioSeedin und unterstützt strategisch den Aufbau globaler Partnerschaften | ACROBiosystems participated in the BIOSeedin Winter Innovation Partnering Summit on January 11, ahead of J.P. Morgan 202 | [Link](https://longbridge.com/en/news/275692064.md) | | Is Sandisk the Next Nvidia? | Sandisk, spun off from Western Digital, has seen its stock surge over 1,500% since its Nasdaq return. As demand for AI i | [Link](https://longbridge.com/en/news/276063622.md) | | What to Expect from Palo Alto Networks's Earnings | Palo Alto Networks (NASDAQ:PANW) is set to release its quarterly earnings report on February 17, 2026, with analysts exp | [Link](https://longbridge.com/en/news/276061399.md) | | 03:00 ETSéptima edición del Concurso S.Pellegrino Young Chef Academy | S.Pellegrino has announced the launch of the seventh edition of the S.Pellegrino Young Chef Academy Competition, aimed a | [Link](https://longbridge.com/en/news/276041621.md) | | Have Insiders Sold Barrick Mining Shares Recently? | Barrick Mining Corporation's Senior EVP & CFO, Graham Shuttleworth, recently sold CA$6.4m worth of shares, reducing his | [Link](https://longbridge.com/en/news/276053765.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.